Bonnie Ky, MD, MSCE, FACC
PHILADELPHIA – Bonnie Ky, MD, MSCE, FACC, an associate professor of Medicine and Epidemiology in the Perelman School of Medicine at the University of Pennsylvania, has been appointed Editor in Chief of the American College of Cardiology’s newest journal – JACC: CardioOncology. The journal will launch in September, and Ky will begin her five-year term in March 2019.
Ky, the founding director of the Penn Cardio-Oncology Center for Excellence, leads research efforts to better understand the cardiotoxic effects of various cancer therapies, focusing on the detection, prevention and treatment of heart disease in cancer patients. In her research, Ky studies advanced imaging, biomarker tools, and deep phenotyping techniques to identify cancer patients who are at increased risk for cardiotoxicity, and to develop strategies to prevent injury while delivering necessary cancer treatments.
As a part of her work, Ky leads a National Institutes of Health (NIH)-funded translational research program in cardio-oncology and is the Principal Investigator of multiple research studies focused on cardiotoxicity. She is also Chair of the Cardiotoxicity Subcommittee for the ECOG-ACRIN Cancer Research Group, which is funded by the National Cancer Institute, and director of the Penn Center for Quantitative Echocardiography.
The journal – which expands the family of JACC journals to eight, including the flagship JACC – will publish original research articles and state-of-the-art reviews related to the leading basic, translational and clinical investigations in cardio-oncology.
Ky received her undergraduate degree from Massachusetts Institute of Technology (M.I.T.) and medical degree from the Perelman School of Medicine at the University of Pennsylvania.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.